drugset / Trial / NCT06387368
Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer
Phase 4
Not yet recruiting
488 enrolled
Xi'an Jiaotong University
Huazhong University of Science and Technology · collabLinkDoc Technology (Beijing) Co. Ltd. · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a prospective, multicenter, randomized, open, parallel controlled clinical study to evaluate the efficacy and safety of Huaier Granules combined with capecitabine in the treatment of unresectable pancreatic cancer.
Timeline
- Start
- 2024-05
- Primary completion
- 2028-03
- Completion
- 2028-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Capecitabine | Small molecule | 1250 mg/m2 | Oral |
| Subject | Huaier Granule | Traditional medicine (herbal / TCM) | 10 g | Oral |